期刊
NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 20, 期 6, 页码 1251-1253出版社
OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfh749
关键词
chemotherapy; Freelite assay; light-chain deposition disease; nephrotic syndrome
A 59-year-old male was diagnosed with nephrotic syndrome secondary to light-chain deposition disease. There was no other evidence of a B cell clonal disorder or amyloidosis; circulating free light chains were identified using a new immunoassay (Freelite) and used to monitor disease progression. Improvement in renal function and proteinuria following VAMP chemotherapy correlated with a reduction in circulating light-chain levels. This case demonstrates a new tool in monitoring light-chain deposition disease in the kidney.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据